Compare · head to head
Il Dong Pharmaceutical vs Ilsung IS
Ilsung IS ranks higher overall — 360 rank 59 vs 53.
Ilsung IS leads on Value (51 vs 46) and Sentiment (59 vs 39). Il Dong Pharmaceutical leads on Quality (58 vs 50) and Growth (62 vs 48). The two are close on Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7249420001 | KR7003120003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | — | |
| Ranks | ||
| 360 | 53 | 59 |
| Value | 46 | 51 |
| Quality | 58 | 50 |
| Growth | 62 | 48 |
| Safety | 47 | 50 |
| Sentiment | 39 | 59 |
| Quality details | ||
| Profitability | 74 | 47 |
| Cash Truth | 42 | 53 |
Il Dong Pharmaceutical vs BoryungIl Dong Pharmaceutical vs Daewon PharmaceuticalIl Dong Pharmaceutical vs Dongwha PharmIl Dong Pharmaceutical vs Daewoong PharmaceuticalAdd a third stock →
Full analyses: Il Dong Pharmaceutical · Ilsung IS
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100